Open Daily: 10am - 10pm | Alley door pickup 10am - 7pm 3038 Hennepin Ave Minneapolis, MN
612-822-4611

  • Open Daily: 10am - 10pm
    Alley-side Pickup: 10am - 7pm

    3038 Hennepin Ave Minneapolis, MN
    612-822-4611

Open Daily: 10am - 10pm | Alley-side Pickup: 10am - 7pm
3038 Hennepin Ave Minneapolis, MN
612-822-4611
Campath - 1 H: Emerging Frontline Therapy in Chronic Lymphocytic Leukemia

Campath - 1 H: Emerging Frontline Therapy in Chronic Lymphocytic Leukemia

Rai, Kanti R.
Stephenson, Janet
Rai, K. R.

Hardcover

Medical Reference

Currently unavailable to order

ISBN10: 1842140604
ISBN13: 9781842140604
Publisher: Informa Medical
Pages: 128
Weight: 1.10
Height: 0.50 Width: 7.60 Depth: 10.00
Language: English
This is the only authoritative, detailed clinical reference on Campath-1H, which stands alone among monoclonal antibodies because its reciprocal antigen CD52 is expressed in diverse cell types, and its further potential for clinical practice in hemato-oncology in the treatment of B-cell chronic lymphocytic leukemia. It records the development and actions of Campath-1H, presents the unique clinical, immunological and molecular features of B-cell chronic lymphocytic leukemia, and explores the potential of Campath-1H as frontline therapy for patients with B-CLL. The book contains five main chapters on B-cell chronic lymphocytic leukemia, the road to remission (from single agent intervention to combination therapy and onward), monoclonal antibodies in cancer (the development of Campath-1H), Campath-1H in B-CLL (remissions of refractory disease), and the role of Campath-1H prior to bone marrow transplant in refractory B-CLL plus a concluding chapter on future perspectives.

Also in

Medical Reference

View All